BBNX

Beta Bionics Stock Analysis

AI Rating

Low
  • Quality5/10
  • Growth↓ 3/10
  • Value↓ 0/10
Beta Bionics sales and earnings growth
BBNX Growth
Neutral
  • Revenue Y/Y↑ 53.94%
  • EPS Y/Y↑ 78.95%
  • FCF Y/Y↓ -8.92%
Beta Bionics gross and profit margin trends
BBNX Profitability
Neutral
  • Gross margin ↑ 55.40%
  • EPS margin↓ -73.00%
  • ROIC 5Y↓ 0.00%
Beta Bionics net debt vs free cash flow
BBNX Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↑ 999.0

Beta Bionics stock volatility is higher than the overall market. We give it a Great risk rating.

More Medical Devices stocks ↗